Jonathan Dry

Boston-based Brit. Curiosity driven, amazed by science. Experienced manager, oncology, pharma R&D, data science. VP Scientific Discovery @TempusLabs

[Jonathan Dry @DrySci]

Are you a skilled #datascientist, passionate about advancing #healthcare and #drugdevelopment. We have a unique opportunity @TempusAI to drive an exciting new endeavor in #precisionmedicine https://t.co/7Zl8EBRnQD #computationalbiology #machinelearning #realworlddata

[Jonathan Dry @DrySci]

@TempusAI #Boston continues to grow, and we are seeking a talented expert in #computationalbiology and #machinelearning to help harness our vast #realworld + #omics database with #pharma partners to drive new #drugdiscovery and #drugdevelopment https://t.co/kH3uISgpwe

[Jonathan Dry @DrySci]

I'm really exited to be expanding our group @TempusAI. We are looking for an experienced #realworlddata scientist to take a leading role applying our vast #multimodal datasets to drive new #drugdevelopment with our #pharma partners https://t.co/MmYd8ERYze #RWE #biostatistics

[Jonathan Dry @DrySci]

I'm really excited to connect with friends, old and new, to learn and celebrate the fantastic advances in #Oncology at the #ESMO conference. If you'll be in Barcelona then I'd love to see you - come and find me at the @TempusAI booth!

[Jonathan Dry @DrySci]

Fancy hearing about how we used #realworlddata to study the potential and practicality of #transcriptomics to stratify #smallcell #lungcancer #prognosis - I'm excited to be talking @bioitworld tomorrow about this @TempusLabs and @AstraZeneca collaboration

[Jonathan Dry @DrySci]

In healthcare "we try to solve problems by building faster and more expensive Ferraris when what we really need are better roads. As a result, our sports cars end up stuck in the mud". Eye opening! https://t.co/aBURlE0tfe

[Jonathan Dry @DrySci]

I love finding new ways for the @TempusLabs platform to help new therapies emerge and reach patients - super excited to work with @pfizer https://t.co/9xquOMowYb

[Jonathan Dry @DrySci]

a Topol perspective on #AI #medicine always gets the ideas flowing... https://t.co/v8xswTIbm1

[Jonathan Dry @DrySci]

Brilliant to see the start of this clinical journey between @TempusLabs and @AstraZeneca to bring opportunities for new #therapy to patients with #smallcell #lungcancer https://t.co/VoCeREVZgN

[Jonathan Dry @DrySci]

The team continues to grow, and we have another opening @TempusLabs #boston for a talented #computationalbiology expert to help us transform #drugdiscovery #drugdevelopment with #genomics #bigdata https://t.co/YMVUC7r3Ic

[Jonathan Dry @DrySci]

@JennaLCollier This could be an ideal opportunity @TempusLabs in Boston https://t.co/YMVUC7rBxK

[Jonathan Dry @DrySci]

#computationalbiology opportunities are still available to join this unique team in #Boston or #Chicago & transform #immunooncology drug R&D with the world’s largest #realworld collection of patient #clinical, #omics and #imaging data

[Jonathan Dry @DrySci]

Passionate about bringing #bigdata to #precisionmedicine and #cancer #drugdevelopment - there's a unique chance for talented individuals in #computationalbiology and #immunooncology to join us @TempusLabs .
https://t.co/YMVUC7IEzK

[Jonathan Dry @DrySci]

Still time to apply for this unique #job opportunity bringing transformational #realworlddata to world leading #pharma R&D....

[Jonathan Dry @DrySci]

Passionate about bringing #bigdata to #precisionmedicine and #cancer #drugdevelopment - there's a unique chance for talented individuals in #computationalbiology and #immunooncology to join us @TempusLabs .
https://t.co/YMVUC7IEzK

[Jonathan Dry @DrySci]

Passionate about bringing #bigdata to #precisionmedicine and #cancer #drugdevelopment - there's a unique chance for talented individuals in #computationalbiology and #immunooncology to join us @TempusLabs .
https://t.co/YMVUC7IEzK

[Jonathan Dry @DrySci]

Proud to be bringing the unique innovation of AstraZeneca ‘s portfolio together with the #realworld #datascience and #clinicalnetwork at Tempus Labs, Inc. to benefit patients with #smallcell #lungcancer https://t.co/WIZrz8WRuL

[Jonathan Dry @DrySci]

#EarlyDetection, #prevention, and #objective and #equal care for all - strong pillars of a strategy to reduce the #cancer death rate by at least 50 percent https://t.co/lhy7FrFOcj

[Jonathan Dry @DrySci]

I'm delighted to have had the opportunity to author this article - the first in what I hope will be a series sharing our experience in #biomarker validation [#oncology #drugdiscovery #diagnostics #genomics]:

[Tempus @TempusAI]

The emergence of cancer #immunotherapies has brought a new level of complexity to the biomarker paradigm. Our VP of scientific discovery @DrySci shares insights on designing validation workflows to increase predictive biomarkers’ probability of success: https://t.co/63g9HeUlcH

[Tempus @TempusAI]

The emergence of cancer #immunotherapies has brought a new level of complexity to the biomarker paradigm. Our VP of scientific discovery @DrySci shares insights on designing validation workflows to increase predictive biomarkers’ probability of success: https://t.co/63g9HeUlcH

[Jonathan Dry @DrySci]

@AstraZeneca Hugely deserved, having been part of the cultural transformation that came about at AstraZeneca I now truly value great leadership and the need to follow the science

[Nature Communications @NatureComms]

.@useless_ulysses @elipapa @KrishnaCBulusu @michaelughetto @dpolychr2 @lostinromsey @drysci @M_Pfiver develop a recommender system ranking genes based on trade-offs between diverse types of evidence linking them to potential mechanisms of EGFRi resistance

https://t.co/0RDZo1XiLQ